Daniel N. Swisher Jr. - 10 Jan 2025 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Director
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Daniel N. Swisher, Jr.
Issuer symbol
CORT
Transactions as of
10 Jan 2025
Net transactions value
-$84,502
Form type
4
Filing time
14 Jan 2025, 19:30:14 UTC
Previous filing
12 Dec 2024
Next filing
12 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $26,686 +2,200 $12.13 2,200 10 Jan 2025 Direct
transaction CORT Common Stock Sale $111,188 -2,200 -100% $50.54 0 10 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -2,200 -21% $0.000000 8,400 10 Jan 2025 Common Stock 2,200 $12.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.
F2 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.